← All stocks

Aurinia Pharmaceuticals Inc.

AUPH Net buying
CIK 0001600620 #1941 in the set updated 17 Sep 2026
Bought (120 mo)
$63.16M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$42.41M
$0.00 on a plan · $21.68M straight out of an exercise
Sold at will
$20.73M
61 of 80 sales
Net
+$20.75M
+$42.43M against sales at will

By person

25 insiders · 130 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
TANG KEVIN
Chief Executive Officer
$62.27M (23)
+$62.27M
13,044,106
9.80%
$208.05M
+80.4%
Solomons Neil
Chief Medical Officer
$13.31M (10) scheduled
−$13.31M
90,953
0.0684%
$1.45M
−51.4%
Martin Michael Robert
Chief Business Officer
$154.80K (1)
$12.85M (19) scheduled
−$12.70M
259,162
0.1948%
$4.13M
−1.9%
Huizinga Robert Bindert
EVP of Research
$5.48M (8) scheduled
−$5.48M
69,379
0.0521%
$1.11M
−33.0%
Greenleaf Peter
Chief Executive Officer
$54.89K (2)
$3.98M (5)
−$3.93M
1,840,379
1.38%
$29.35M
+448.8%
Robertson Stephen P.
Chief Legal Officer
$14.53K (1)
$2.02M (6)
−$2.00M
588,848
0.4426%
$9.39M
+413.0%
Miller Joseph M
Chief Financial Officer
$9.74K (1)
$1.27M (5)
−$1.26M
576,421
0.4332%
$9.19M
+396.1%
Donley Matthew Maxwell
Chief Operating Officer
$146.34K (2)
$1.26M (4)
−$1.11M
680,299
0.5113%
$10.85M
+474.2%
Hagan Joseph P
Director
$906.53K (3) scheduled
−$906.53K
11,961
0.0090%
$190.78K
+241.7%
Keenan Greg
SVP, Chief Medical Officer
$376.26K (3)
−$376.26K
154,449
0.1161%
$2.46M
+38.6%
MILNE GEORGE M JR
Director
$297.38K (3)
+$297.38K
78,733
0.0592%
$1.26M
+96.8%
Habig Scott Michael
Chief Commercial Officer
$25.08K (1)
$283.40K (3)
−$258.33K
456,338
0.3430%
$7.28M
+231.8%
Knappertz Volker
EVP, Research and Development
$167.87K (2)
−$167.87K
319,128
0.2399%
$5.09M
+102.3%
Jayne David R.W.
Director
$126.72K (2)
−$126.72K
56,499
0.0425%
$901.16K
+41.2%
Billen Daniel
Director
$82.51K (2)
−$82.51K
28,141
0.0212%
$448.85K
+40.7%
Smith Karen L.
Director
$44.18K (1)
−$44.18K
24,807
0.0186%
$395.67K
Colao Massimilano
Chief Commercial Officer
$38.49K (1)
−$38.49K
13,495
0.0101%
$215.25K
+64.6%
Bailey Jeffrey Allen
Director
$38.42K (1)
−$38.42K
22,775
0.0171%
$363.26K
MacKay-Dunn R. Hector
Former Director
$105.51K (5)
$86.57K (2)
+$18.95K
18,595
0.0140%
$296.59K
+1,140%
Balakrishnan Brinda
Director
$2.98K (1)
−$2.98K
17,523
0.0132%
$279.49K
Leversage Jill
Director
$85.10K (4)
$86.42K (2)
−$1.32K
26,453
0.0199%
$421.93K
+2,545%
Hearne Michael S
Chief Financial Officer
116,144
0.0873%
$1.85M
Cole Ryan
Chief Operating Officer
116,144
0.0873%
$1.85M
Hayden Michael R
Director
95,000
0.0714%
$1.52M
Johnson Craig A
Director
14,592
0.0110%
$232.74K
Insider
Date
Role
Action
Shares
Price
Amount
TANG KEVIN
2 Jun 2026
Chief Executive Officer
Buy indirect
206,005
$15.28
$3.15M
TANG KEVIN
1 Jun 2026
Chief Executive Officer
Buy indirect
99
$15.34
$1.52K
TANG KEVIN
1 Jun 2026
Chief Executive Officer
Buy indirect
343,521
$15.28
$5.25M
TANG KEVIN
29 May 2026
Chief Executive Officer
Buy indirect
262,682
$15.31
$4.02M
TANG KEVIN
29 May 2026
Chief Executive Officer
Buy indirect
2,299
$15.35
$35.29K
TANG KEVIN
3 Mar 2026
Director
Buy indirect
184,208
$14.22
$2.62M
TANG KEVIN
2 Mar 2026
Director
Buy indirect
115,792
$14.21
$1.65M
TANG KEVIN
2 Mar 2026
Director
Buy indirect
83,561
$14.33
$1.20M
TANG KEVIN
27 Feb 2026
Director
Buy indirect
1,600
$14.38
$23.01K
TANG KEVIN
27 Feb 2026
Director
Buy indirect
214,839
$14.12
$3.03M
TANG KEVIN
27 Feb 2026
Director
Buy indirect
300,000
$13.90
$4.17M
TANG KEVIN
5 Aug 2025
Director
Buy indirect
200,000
$11.68
$2.34M
TANG KEVIN
4 Aug 2025
Director
Buy indirect
100,000
$11.34
$1.13M
TANG KEVIN
1 Aug 2025
Director
Buy indirect
1,000,000
$10.12
$10.12M
TANG KEVIN
4 Mar 2025
Director
Buy indirect
100,000
$8.09
$809.00K
TANG KEVIN
4 Mar 2025
Director
Buy indirect
500,000
$7.92
$3.96M
TANG KEVIN
4 Mar 2025
Director
Buy indirect
148,038
$8.00
$1.18M
TANG KEVIN
3 Mar 2025
Director
Buy indirect
351,962
$8.02
$2.82M
TANG KEVIN
3 Mar 2025
Director
Buy indirect
100,720
$7.97
$802.74K
TANG KEVIN
28 Feb 2025
Director
Buy indirect
399,280
$7.85
$3.13M
TANG KEVIN
9 Dec 2024
Director
Buy indirect
500,000
$9.09
$4.55M
TANG KEVIN
6 Dec 2024
Director
Buy indirect
400,000
$9.01
$3.60M
TANG KEVIN
5 Dec 2024
Director
Buy indirect
300,000
$8.91
$2.67M
MILNE GEORGE M JR
2 Mar 2023
Director
Buy
20,000
$8.91
$178.28K
Donley Matthew Maxwell
21 Nov 2022
Ex VP, Internal Operations
Buy
10,000
$4.66
$46.60K
Habig Scott Michael
9 Nov 2022
Chief Commercial Officer
Buy
5,000
$5.02
$25.08K
Martin Michael Robert
7 Nov 2022
Chief Business Officer
Buy
30,000
$5.16
$154.80K
MacKay-Dunn R. Hector
9 Mar 2022
Director
Buy
5,000
$11.00
$54.99K
MILNE GEORGE M JR
4 Mar 2022
Director
Buy
5,000
$10.82
$54.10K
Leversage Jill
13 Dec 2021
Director
Buy
1,600
$20.04
$32.06K
MacKay-Dunn R. Hector
12 May 2021
Director
Buy
1,600
$11.28
$18.04K
MacKay-Dunn R. Hector
12 May 2021
Director
Buy
1,400
$11.26
$15.76K
Miller Joseph M
11 May 2021
Chief Financial Officer
Buy
1,000
$9.74
$9.74K
Leversage Jill
11 May 2021
Director
Buy
2,500
$10.96
$27.39K
Greenleaf Peter
11 May 2021
Chief Executive Officer
Buy
2,992
$11.11
$33.24K
Greenleaf Peter
11 May 2021
Chief Executive Officer
Buy
2,133
$10.15
$21.65K
Donley Matthew Maxwell
11 May 2021
Ex VP, Intern'l Operations
Buy
9,900
$10.07
$99.74K
MacKay-Dunn R. Hector
11 May 2021
Director
Buy
1,000
$11.14
$11.14K
MacKay-Dunn R. Hector
11 May 2021
Director
Buy
500
$11.17
$5.59K
MILNE GEORGE M JR
5 Mar 2021
Director
Buy
5,000
$13.00
$65.00K
Leversage Jill
29 Jan 2021
Director
Buy
1,200
$16.03
$19.24K
Leversage Jill
29 Jan 2021
Director
Buy indirect
400
$16.03
$6.41K
Robertson Stephen P.
28 Jan 2021
EVP, General Counsel
Buy
900
$16.14
$14.53K

What was left out

Form 4 filings counted 150
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 19
Sales at will 61
Transactions with no price 0
Shares from compensation/vesting 7,752,523
Sales filed before the plan box existed 27
History held since 29 Jan 2021